MedPath
FDA Approval

TERBINAFINE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
direct rx
DUNS: 079254320
Effective Date
July 23, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Terbinafine(250 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

direct rx

079254320

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

direct rx

direct rx

direct rx

079254320

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TERBINAFINE

Product Details

NDC Product Code
72189-243
Application Number
ANDA078297
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
July 23, 2021
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
Code: 012C11ZU6GClass: ACTIMQuantity: 250 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4Class: IACT
© Copyright 2025. All Rights Reserved by MedPath